PUBLISHER: TechNavio | PRODUCT CODE: 1261925
PUBLISHER: TechNavio | PRODUCT CODE: 1261925
Technavio has been monitoring the microfluidic market for healthcare application and is forecast to grow by USD 59.76 bn during 2022-2027, accelerating at a CAGR of 20.16% during the forecast period. Our report on the microfluidic market for healthcare application provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by compact size of microfluidic devices, growth in lifestyle diseases, and advances in DNA sequencing.
Technavio's microfluidic market for healthcare application is segmented as below:
By Application
By Material
By Geography
This study identifies the use of paper-based microfluidic devices as one of the prime reasons driving the microfluidic market growth during the next few years. Also, the introduction of soft robots and increasing applications of microfluidics in drug delivery technologies will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the microfluidic market for healthcare application covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microfluidic market vendors that include 908 Devices Inc., Agilent Technologies Inc., bioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Bonaduz AG, Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., uFluidix Inc., and QIAGEN NV. Also, the microfluidic market for healthcare application analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: